Effect of Virtual Reality on Anxiety, Depression, Stress and Death anxiety in Elderly

Not Applicable

Recruiting

• Conditions: Condition 1: Depression. Condition 2: Anxiety. Condition 3: Stress. Condition 4: Death anxiety.; Other depressive episodes; Other anxiety disorders; Other reactions to severe stress; F32.8; F43.8

• Registration Number: IRCT20221130056669N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Individuals aged 60 years and older
Reading and writing literacy in Persian language
Interest and informed consent to participate in the study
Absence of visual, auditory, or tactile impairments
Achieving a score of eight or above on the Abbreviated Mental Test (AMT)
Absence of psychological disorders as determined by both file records and self-reported measures
Absence of current use of psychiatric medications or narcotics as determined by both file records and self-reported measures.
Absence of medical history pertaining to conditions such as epilepsy, dizziness, and convulsions, as confirmed by both file records and self-reported measures.
Absence of self-reported prior participation in comparable programs
Achieving a score of 14 or greater on the depression subscale of the Depression Anxiety Stress Scale-21 (DASS-21).
Achieving a score of 10 or greater on the Anxiety subscale of the Depression Anxiety Stress Scale-21(DASS-21)
Achieving a score 19 or greater on the Stress subscale of the Depression Anxiety Stress Scale-21(DASS-21)
Achieving a score 7 and above in the Tampler Death anxiety Scale (DAS)

Exclusion Criteria

Sensory impairments in vision, hearing, and tactile
Suffering from psychological disorders, according to the file and self-report
Taking psychiatric medicine and narcotics according to the file and self-report
Having a history of diseases such as epilepsy, dizziness and convulsions according to the file and self-report

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score from depression subscale, short form of depression, anxiety and stress scale. Timepoint: Before and after the intervention. Method of measurement: Short form of depression, anxiety and stress scale(DASS-21).;Score from ?anxiety subscale, short form of depression, anxiety and stress scale. Timepoint: Before and after intervention. Method of measurement: Short form of depression, anxiety and stress scale(DASS-21).;Score from ?stress subscale, short form of depression, anxiety and stress scale. Timepoint: Before and after intervention. Method of measurement: Short form of depression, anxiety and stress scale (DASS-21).;Score from ?Tampler Death anxiety scale. Timepoint: Before and after intervention. Method of measurement: Tampler Death anxiety scale (DAS).